Iridex reiterated its financial outlook for 2023, expecting Cyclo G6 probe sales of 65,000 to 67,000 representing approximately 9% to 12% growth over 2022 and to expand the Cyclo G6 systems installed base by 225 to 250 systems. Total revenue for the full year is expected to be $57 million to $59 million. 2023 total revenue guidance represents growth of approximately 3% to 6% after adjusting for an approximate $1.5 million reduction of Other Revenue royalty income resulting from the expiration of licensed patents.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 USD | -0.75% | -7.72% | -6.41% |
05-14 | Transcript : IRIDEX Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Earnings Flash (IRIX) IRIDEX CORPORATION Posts Q1 Revenue $11.8M, vs. Street Est of $12M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.41% | 42.75M | |
+12.50% | 228B | |
+14.52% | 196B | |
+17.51% | 141B | |
+28.96% | 110B | |
+1.33% | 65.88B | |
+18.16% | 54.3B | |
+7.63% | 52.39B | |
+10.95% | 45.22B | |
+5.10% | 37.12B |
- Stock Market
- Equities
- IRIX Stock
- News IRIDEX Corporation
- IRIDEX Corporation Reiterates Financial Guidance for 2023